![Amy Vandekop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Vandekop
No open positions remaining
Net worth: 3 830 $ as of 2026-08-30
Profile
Ms. Amy Vandekop, CPA, is a Chief Accounting Officer & Controller at Kalaris Therapeutics, Inc. Ms. Vandekop was previously employed as a Senior Director-Accounting & Reporting by AlloVir, Inc. and a Senior Manager-Accounting & Reporting by Lumicell, Inc. She received her undergraduate degree from the University of Massachusetts Amherst.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0% | 2026-08-26 | 948 ( 0% ) | 3 830 $ | 2026-08-30 |
Amy Vandekop active positions
| Companies | Position | Start |
|---|
Former positions of Amy Vandekop
| Companies | Position | End |
|---|---|---|
| ALLOVIRPAR | Comptroller/Controller/Auditor | 2025-02-28 |
Lumicell, Inc.
 Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and markets image-guided cancer surgery solutions | Comptroller/Controller/Auditor | 2020-11-30 |
Training of Amy Vandekop
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
30
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Lumicell, Inc.
Lumicell, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and markets image-guided cancer surgery solutions | Electronic Technology |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
University of Massachusetts Amherst
 University of Massachusetts Amherst Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Amy Vandekop
